Multiple symmetric lipomatosis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2398OMIM:151800E88.8
Who is this for?
Show terms as
1Active trials13Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Multiple symmetric lipomatosis (MSL), also known as Madelung disease or Launois-Bensaude syndrome, is a rare disorder of fat metabolism characterized by the progressive, symmetric accumulation of non-encapsulated fatty masses (lipomas) around the neck, shoulders, upper arms, upper back, and trunk. These fatty deposits are typically painless but can become disfiguring and, when located in the neck region, may compress the airway, esophagus, or major blood vessels, leading to breathing difficulties, swallowing problems, or vascular complications. The condition predominantly affects middle-aged men, and there is a strong association with chronic alcohol use, though cases in non-drinkers have also been reported. MSL primarily affects the adipose tissue but can also be associated with metabolic abnormalities including dyslipidemia, glucose intolerance, insulin resistance, hyperuricemia, and liver disease. Peripheral neuropathy is a frequently observed complication, which may be related to alcohol use or to the underlying metabolic disturbance itself. Some cases have been linked to mitochondrial DNA mutations, particularly in the MT-TK gene encoding tRNA-Lys, suggesting a mitochondrial component in at least a subset of patients. There is no curative treatment for MSL. Management primarily involves surgical removal of lipomatous masses through conventional lipectomy or liposuction, though recurrence after surgery is common. Alcohol cessation is strongly recommended and may slow disease progression, although it does not typically lead to regression of existing fatty deposits. Weight management and treatment of associated metabolic conditions such as diabetes and dyslipidemia are important components of care. Monitoring for airway compromise and peripheral neuropathy is also essential in long-term follow-up.

Also known as:

Clinical phenotype terms— hover any for plain English:

Abnormal adipose tissue morphologyHP:0009124
Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

2 events
Aug 2023Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)

University of Michigan — PHASE2

TrialACTIVE NOT RECRUITING
Jun 2021Prospective Study on the Consequences of Weight Loss After Bariatric Surgery on Obese Patients' Spine.

Assistance Publique - Hôpitaux de Paris — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Multiple symmetric lipomatosis.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
Phase 21 trial
Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL)
Phase 2
Active
PI: Elif Oral (University of Michigan) · Sites: Ann Arbor, Michigan · Age: 060 yrs

Specialists

13 foundView all specialists →
AS
Anne Sheu
Specialist
PI on 1 active trial1 Multiple symmetric lipomatosis publication
PM
Paul Orchard, MD
MINNEAPOLIS, MN
Specialist
PI on 15 active trials
EO
Elif Oral
ANN ARBOR, MI
Specialist
PI on 1 active trial21 Multiple symmetric lipomatosis publications
LM
Lisa J McReynolds, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 2 active trials
LS
Laurent Servais
Specialist
PI on 1 active trial28 Multiple symmetric lipomatosis publications
JM
Jennie Brand Miller
Specialist
PI on 3 active trials212 Multiple symmetric lipomatosis publications
LB
Lauri M. Burroughs
SEATTLE, WA
Specialist
PI on 1 active trial3 Multiple symmetric lipomatosis publications
SM
Salim Hayek, MD
GALVESTON, TX
Specialist
PI on 4 active trials
EP
Emmanuelle FERRERO, MD, PHD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Multiple symmetric lipomatosis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Multiple symmetric lipomatosisForum →

No community posts yet. Be the first to share your experience with Multiple symmetric lipomatosis.

Start the conversation →

Latest news about Multiple symmetric lipomatosis

Disease timeline:

New recruiting trial: Prospective Study on the Consequences of Weight Loss After Bariatric Surgery on Obese Patients' Spine.

A new clinical trial is recruiting patients for Multiple symmetric lipomatosis

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Multiple symmetric lipomatosis

What is Multiple symmetric lipomatosis?

Multiple symmetric lipomatosis (MSL), also known as Madelung disease or Launois-Bensaude syndrome, is a rare disorder of fat metabolism characterized by the progressive, symmetric accumulation of non-encapsulated fatty masses (lipomas) around the neck, shoulders, upper arms, upper back, and trunk. These fatty deposits are typically painless but can become disfiguring and, when located in the neck region, may compress the airway, esophagus, or major blood vessels, leading to breathing difficulties, swallowing problems, or vascular complications. The condition predominantly affects middle-aged m

At what age does Multiple symmetric lipomatosis typically begin?

Typical onset of Multiple symmetric lipomatosis is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Multiple symmetric lipomatosis?

Yes — 1 recruiting clinical trial is currently listed for Multiple symmetric lipomatosis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Multiple symmetric lipomatosis?

13 specialists and care centers treating Multiple symmetric lipomatosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.